Comments Off on Thoughts on Joining Foresite Labs by Uplaksh Kumar
Comments Off on BIOS Builders Interview with Mark Chao, Co-founder & CEO at TenSixteen Bio
Comments Off on Foresite Labs’ new $173M fund to bankroll fewer startups but ‘big ideas’ fueled by data
Comments Off on Foresite Capital Launches $173M Fund to Support Incubated Companies
Comments Off on With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to numerous diseases
Comments Off on TenSixteen Bio Launches With $40M Series A To Advance A New Approach To Disease Detection And Treatment
Comments Off on Foresite Labs Hatches Big-Data-Driven Companies Destined to Shake up Healthcare
Comments Off on Seven Biopharma Trends to Watch in 2022
Comments Off on Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis
Comments Off on Top Life Sciences Startups to Watch in 2022